Shares in Redx Pharma (REDX) jumped 17 per cent on news the pharmaceutical development company has reached the pre-clinical development stage of a drug that could be used to fight the superbug MRSA. The discovery was hailed as a significant milestone for Redx's commercial partnership with the NHS, and means three of the company's development programs have identified new drug candidates since January.
IC TIP:
Buy
at
124p
The NHS collaboration, formed in 2013 to combat the growing threat of drug-resistant bacteria, will now test the drug's efficacy in pre-clinical trials, ahead of anticipated commercialisation.